Asparaginase Erwinia chrysanthemi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Asparaginase Erwinia chrysanthemi, covering 2026-03-17 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]